![Douglas Ingram](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Ingram
Vorstandsvorsitzender bei
SAREPTA THERAPEUTICS, INC.
Vermögen: 12 Mio $ am 30.06.2026
Profil
Douglas S. Ingram bekleidet die Position des President, Chief Executive Officer & Director bei Sarepta Therapeutics, Inc. Er ist außerdem Mitglied des Vorstands der Allergan Foundation und von Relay Therapeutics, Inc. Zuvor war er als Rechtsanwalt bei Gibson, Dunn & Crutcher LLP, als Chief Executive Officer & Director bei Chase Pharmaceuticals Corp. und als Präsident bei Allergan, Inc. tätig. Herr Ingram erwarb einen Bachelor-Abschluss an der Arizona State University und einen Master-Abschluss an der University of Arizona.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.04.2026 | 390’307 ( 0.37% ) | 7 Mio $ | 30.06.2026 | |
| 15.01.2026 | 59’016 ( 0.04% ) | 5 Mio $ | 30.06.2026 | |
| 09.06.2026 | 25’000 ( 0.01% ) | 467 750 $ | 30.06.2026 |
Aktuelle Nachrichten zu Douglas Ingram
Aktive Positionen von Douglas Ingram
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Vorstandsvorsitzender | 26.06.2017 |
| RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
Allergan Foundation
 Allergan Foundation Medical/Nursing ServicesHealth Services The Allergan Foundation, operating under AbbVie, provides information and support related to Botox® (onabotulinumtoxinA), a prescription treatment for severe primary axillary hyperhidrosis (severe underarm sweating) in adults when topical medicines are insufficient. The non-profit company is based in Irvine, CA. Botox® is administered by medical professionals and can offer relief for up to approximately seven months. The foundation details the clinical assessment process, important safety information, potential side effects, and the need for patients to disclose medical conditions and medications before treatment. AbbVie also offers patient support programs to assist with medication access and costs. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Douglas Ingram
| Unternehmen | Position | Ende |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.03.2026 |
Pacific Mutual Holding Co.
 Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Direktor/Vorstandsmitglied | 01.05.2018 |
| SKYE BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 19.01.2018 |
| ENDO INTERNATIONAL PLC | Direktor/Vorstandsmitglied | 06.11.2017 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Vorstandsvorsitzender | 01.11.2016 |
Ausbildung von Douglas Ingram
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gibson, Dunn & Crutcher, Inc.
 Gibson, Dunn & Crutcher, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Finance |
ECC Capital Corp.
 ECC Capital Corp. Real Estate Investment TrustsFinance Provides mortgage finance real estate investment trust services | Finance |
Volcom, Inc.
 Volcom, Inc. Apparel/FootwearConsumer Non-Durables Manufactures and distributes clothes and accessories | Consumer Non-Durables |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Life Insurance Co.
 Pacific Life Insurance Co. Life/Health InsuranceFinance Provides life insurance products, annuities and mutual funds solutions | Finance |
Allergan Foundation
Allergan Foundation Medical/Nursing ServicesHealth Services The Allergan Foundation, operating under AbbVie, provides information and support related to Botox® (onabotulinumtoxinA), a prescription treatment for severe primary axillary hyperhidrosis (severe underarm sweating) in adults when topical medicines are insufficient. The non-profit company is based in Irvine, CA. Botox® is administered by medical professionals and can offer relief for up to approximately seven months. The foundation details the clinical assessment process, important safety information, potential side effects, and the need for patients to disclose medical conditions and medications before treatment. AbbVie also offers patient support programs to assist with medication access and costs. | Health Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
